Back

LE8 score in relation to cardiovascular disease and mortality in individuals with diabetes

1 September 2024 (13:33 - 13:42)
Organised by: Logo
Congress Presentation Part of: Risk scores in different populations Scores ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Zhangling Chen

The Second Xiangya Hospital of Central South University, Changsha (China)

6 More presentations in this session

Presentation thumbnail
Association of lifes essential 8 and mortality among adults with and without CVD
Doctor O. Kobo (Hadera, IL)
Abstract Slides Video
Presentation thumbnail
Adding ethnicity to cardiovascular risk prediction: external validation and model updating of SCORE2 using data from the multiethnic HELIUS population cohort
Mr J. Van Apeldoorn (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Prediction of 10-year risk for recurrent atherosclerotic cardiovascular events in a secondary prevention population: Insights from CHART-2 and Suita studies in the Japanese population
Doctor K. Oyama (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Implications of five different risk models in primary prevention guidelines
Doctor M. Sud (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Polygenic prediction of coronary artery disease among 130,000 Mexican adults
Miss T. Liu (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Risk scores in different populations
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 13:33 CET
You may be interested in
thumbnail
Congress Presentation
Independent associations of educational attainment and its joint associations with LE8 score for risk of cardiovascular disease incidence and mortality among Chinese people
thumbnail
Congress Presentation
Association of Life's Essential 8 metrics with mortality outcomes in US cancer survivors
thumbnail
Congress Presentation
Association between life's essential 8 score and 5-year all-cause and cardiovascular mortality in people with prediabetes: based on a cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources